Approvals/TGA/ATECTURA BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler

Approved

STANDARD

ATECTURA BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler

Novartis Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: a52ba7961d8759e6
Company: Novartis Pharmaceuticals Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: a52ba7961d8759e6
Product Name: ATECTURA BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler
Artg Id: 319074
Artg Name: ATECTURA BREEZHALER 125/260 indacaterol (as acetate)/mometasone furoate 125/260 microgram powder for inhalation in hard capsule with inhaler
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2020-07-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2553f1cf2f99628c9f83a2cacd8f0d95.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/9d59238561ab17f0d91f0013d19e3700.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a52ba7961d8759e6

Type

Standard

Back to TGA Approvals